Guggenheim Initiates Q32 Bio(QTTB.US) With Buy Rating, Announces Target Price $100
Guggenheim analyst Yatin Suneja initiates coverage on $Q32 Bio(QTTB.US)$ with a buy rating, and sets the target price at $100.According to TipRanks data, the analyst has a success rate of 44.6% and a
Market-Moving News for June 17th
BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106ZYME: 13% | Zymeworks shares are trading higher after the FDA cleared the company's Investigational New Drug application for Zw171
Express News | Q32 Bio Shares Are Trading Higher After Guggenheim Initiated Coverage With a Buy Rating and a $100 Price Target
Q32 Bio Initiated at Buy by Guggenheim
Q32 Bio Initiated at Buy by Guggenheim
Express News | Guggenheim Initiates Coverage On Q32 Bio With Buy Rating, Announces Price Target of $100
Buy Rating Justified by Q32 Bio's Promising Pipeline and Market Potential
Express News | Q32 Bio Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $54
Q32 Bio (QTTB) Gets a Buy From Oppenheimer
Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
Express News | Q32 Bio Reports Q1 2024 GAAP EPS Of $(6.33)
Q32 Bio | 10-Q: Quarterly report
Express News | Q32 Bio: Qtrly Shr Loss $6.33
Express News | Q32 Bio: Cash, Equivalents, Short-Term Investments to Provide Financial Runway Through 4 Phase 2 Clinical Milestones and Into Mid-2026
Express News | Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Express News | Q32 Bio Files Prospectus Relates To Proposed Offer, Resale Or Other Disposition From Time To Time By Selling Stockholders Of Up To 1.7M Shares
Express News | Q32 Bio Files Prospectus Relates to Proposed Offer, Resale or Other Disposition From Time to Time by Selling Stockholders of up to 1.7 Mln Shares
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
12 Health Care Stocks Moving In Friday's Intraday Session
GainersPaxMedica (NASDAQ:PXMD) stock increased by 110.9% to $0.87 during Friday's regular session. The company's market cap stands at $6.4 million. Q32 Bio (NASDAQ:QTTB) shares rose 23.89% to $29.5. T
Oppenheimer Starts Q32 Bio at Outperform, Cites Lead Asset
Express News | Q32 Bio Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $50
No Data